These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 28685525)

  • 81. Does a polarization state exist for mast cells in cancer?
    Presta I; Donato A; Zaffino P; Spadea MF; Mancuso T; Malara N; Chiefari E; Donato G
    Med Hypotheses; 2019 Oct; 131():109281. PubMed ID: 31443770
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Interleukin-6: A promising cytokine to support liver regeneration and adaptive immunity in liver pathologies.
    Naseem S; Hussain T; Manzoor S
    Cytokine Growth Factor Rev; 2018 Feb; 39():36-45. PubMed ID: 29361380
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils.
    Galli SJ; Borregaard N; Wynn TA
    Nat Immunol; 2011 Oct; 12(11):1035-44. PubMed ID: 22012443
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Recent progress on pathophysiology, inflammation and defense mechanism of mast cells against invading microbes: inhibitory effect of IL-37.
    Conti P; Caraffa A; Ronconi G; Frydas I; Theoharides TC
    Cent Eur J Immunol; 2019; 44(4):447-454. PubMed ID: 32140058
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Mast Cell-Targeted Strategies in Cancer Therapy.
    Ammendola M; Sacco R; Sammarco G; Luposella M; Patruno R; Gadaleta CD; Sarro GD; Ranieri G
    Transfus Med Hemother; 2016 Mar; 43(2):109-13. PubMed ID: 27330532
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Low-grade chronic inflammation mediated by mast cells in fibromyalgia: role of IL-37.
    Mastrangelo F; Frydas I; Ronconi G; Kritas SK; Tettamanti L; Caraffa Al; D Ovidio C; Younes A; Gallenga CE; Conti P
    J Biol Regul Homeost Agents; 2018; 32(2):195-198. PubMed ID: 29684996
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Interleukin-1 and Related Cytokines in the Regulation of Inflammation and Immunity.
    Mantovani A; Dinarello CA; Molgora M; Garlanda C
    Immunity; 2019 Apr; 50(4):778-795. PubMed ID: 30995499
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Innate immunity and its regulation by mast cells.
    St John AL; Abraham SN
    J Immunol; 2013 May; 190(9):4458-63. PubMed ID: 23606723
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Interrelationship between inflammatory cytokines (IL-1, IL-6, IL-33, IL-37) and acquired immunity.
    Franza L; Carusi V; Altamura S; Caraffa A; Gallenga CE; Kritas SK; Ronconi G; Conti P; Pandolfi F
    J Biol Regul Homeost Agents; 2019; 33(5):1321-1326. PubMed ID: 31663301
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Mast cell phenotypic plasticity and their activity under the influence of cathelicidin-related antimicrobial peptide (CRAMP) and IL-33 alarmins.
    Agier J; Brzezińska-Błaszczyk E; Różalska S; Wiktorska M; Kozłowska E; Żelechowska P
    Cell Immunol; 2021 Nov; 369():104424. PubMed ID: 34469845
    [TBL] [Abstract][Full Text] [Related]  

  • 91. The role of IL-17-secreting mast cells in inflammatory joint disease.
    Kenna TJ; Brown MA
    Nat Rev Rheumatol; 2013 Jun; 9(6):375-9. PubMed ID: 23229447
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Impact of polyphenols on mast cells with special emphasis on the effect of quercetin and luteolin.
    Shaik Y; Caraffa A; Ronconi G; Lessiani G; Conti P
    Cent Eur J Immunol; 2018; 43(4):476-481. PubMed ID: 30799996
    [TBL] [Abstract][Full Text] [Related]  

  • 93. The putative role of mast cells in lung transplantation.
    Jungraithmayr W
    Am J Transplant; 2015 Mar; 15(3):594-600. PubMed ID: 25693471
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Alexithymia and its relationships with inflammatory response mediated by IL-1 family members.
    Conti C; Caraffa Al; Kritas SK; Ronconi G; Fulcheri M
    J Biol Regul Homeost Agents; 2017; 31(1):21-28. PubMed ID: 28337867
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Mast Cell-Mediated Mechanisms of Nociception.
    Aich A; Afrin LB; Gupta K
    Int J Mol Sci; 2015 Dec; 16(12):29069-92. PubMed ID: 26690128
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Inflammation and antiangiogenesis in cancer.
    Ribatti D; Crivellato E; Vacca A
    Curr Med Chem; 2012; 19(7):955-60. PubMed ID: 22214461
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Introduction: Evolution of inflammatory arthritis from innate to adaptive immune mechanisms.
    Kuhn KA; Morrison TE
    Immunol Rev; 2020 Mar; 294(1):5-8. PubMed ID: 32103544
    [No Abstract]   [Full Text] [Related]  

  • 98. Mast cells contribute to coronavirus-induced inflammation: new anti-inflammatory strategy.
    Kritas SK; Ronconi G; Caraffa A; Gallenga CE; Ross R; Conti P
    J Biol Regul Homeost Agents; 2020 January-February,; 34(1):9-14. PubMed ID: 32013309
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Editorial: Emerging Roles for Type 2-Associated Cells and Cytokines in Cancer Immunity.
    Schiavoni G; Munitz A; Strid J
    Front Immunol; 2021; 12():811125. PubMed ID: 34899766
    [No Abstract]   [Full Text] [Related]  

  • 100. Dr. Jekyll and Mr. Hyde: MAP17's up-regulation, a crosspoint in cancer and inflammatory diseases.
    García-Heredia JM; Carnero A
    Mol Cancer; 2018 Apr; 17(1):80. PubMed ID: 29650022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.